Hyperglycaemia following immune checkpoint inhibitor therapy-Incidence, aetiology and assessment. Mulla K, Farag S, Moore B, Matharu S, et al. Diabet Med 2023;40:e15053.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mulla K, Farag S, Moore B, Matharu S, et al. Hyperglycaemia following immune checkpoint inhibitor therapy-Incidence, aetiology and assessment. Diabet Med 2023;40:e15053.
PMID: 36696014